Ignite Creation Date:
2024-05-06 @ 2:03 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01967576
Status:
COMPLETED
Last Update Posted:
2021-01-06
First Post:
2013-10-19
Brief Title:
Phase II Study of Axitinib AG-013736 With Evaluation of the VEGF-pathway in Metastatic Recurrent or Primary Unresectable PheochromocytomaParaganglioma
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC